LPS has been shown to promote the development of pancreatic cancer by blocking the MyD88-dependent pathway while blocking TLR4 and MyD88-independent pathway has a protective effect on pancreatic cancer (156). The gene discussed is MYD88; the disease is familial pancreatic carcinoma.